Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Arch Biochem Biophys ; 539(2): 230-8, 2013 Nov 15.
Article in English | MEDLINE | ID: mdl-24071514

ABSTRACT

ß-Carotene 15,15'-monooxygenase (CMO1, BCMO1) converts ß-carotene to retinaldehyde (retinal) and is a key enzyme in vitamin A metabolism. CMO1 activity is robust in the intestine and liver, where cmo1 gene transcription may be subject to negative feedback by accumulation of its metabolic products. Evidence from CMO1 null animals also indicates that non-gastrointestinal CMO1 may be required for tissue-specific conversion of ß-carotene into vitamin A. The aim of this study was to investigate the effects of the enzymatic substrate, ß-carotene, on regulation of CMO1 in a cell model of human alveolar pneumocytes. We demonstrate that CMO1 is expressed in human alveolar epithelial (A549) cells and converts ß-carotene into retinal and biologically active retinoic acids (RA). Exposure to ß-carotene suppresses CMO1 expression at both mRNA and protein levels. ß-Carotene, but not all-trans RA, decreases CMO1 promoter activity in a time- and dosage-dependent manner. This ß-carotene-mediated inhibition of CMO1 expression results from decreased binding of peroxisome proliferator-activated receptor γ (PPARγ) and retinoid X receptor α (RXRα) in the CMO1 promoter. ß-Carotene treatment also antagonizes PPARγ activity in HEK293 cells that stably express CMO1 wild-type, but not in cells that express the CMO1 mutant or vector alone. These findings have implications for local vitamin A synthesis in the lung, especially during systemic vitamin A insufficiency and may also help to explain, in part, the mechanism underlying the increased lung cancer risk upon ß-carotene supplementation in smokers.


Subject(s)
Gene Expression Regulation, Enzymologic , Pulmonary Alveoli/enzymology , Respiratory Mucosa/metabolism , beta Carotene/physiology , beta-Carotene 15,15'-Monooxygenase/genetics , Cell Line, Tumor , Down-Regulation/genetics , HEK293 Cells , Humans , PPAR gamma/antagonists & inhibitors , PPAR gamma/genetics , PPAR gamma/metabolism , Protein Binding/genetics , Pulmonary Alveoli/pathology , Pulmonary Alveoli/physiology , Respiratory Mucosa/enzymology , Respiratory Mucosa/pathology , Up-Regulation/genetics , beta Carotene/metabolism , beta-Carotene 15,15'-Monooxygenase/antagonists & inhibitors , beta-Carotene 15,15'-Monooxygenase/biosynthesis
2.
Am J Physiol Lung Cell Mol Physiol ; 288(4): L718-26, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15579623

ABSTRACT

Prolonged exposure to supraphysiological oxygen concentrations results in the generation of reactive oxygen species, which can cause significant lung injury in critically ill patients. Supplementation with human recombinant antioxidant enzymes (AOE) may mitigate hyperoxic lung injury, but it is unclear which combination and concentration will optimally protect pulmonary epithelial cells. First, stable cell lines were generated in alveolar epithelial cells (MLE12) overexpressing one or more of the following AOE: Mn superoxide dismutase (MnSOD), CuZnSOD, or glutathione peroxidase 1. Next, A549 cells were transduced with 50-300 particles/cell of recombinant adenovirus containing either LacZ or each of the three AOE (alone or in combination). Cells were then exposed to 95% O(2) for up to 3 days, with cell number and viability determined daily. Overexpression of either MnSOD (primarily mitochondrial) or CuZnSOD (primarily cytosolic) reversed the growth inhibitory effects of hyperoxia within the first 48 h of exposure, resulting in a significant increase in viable cells (P < 0.05), with 1.5- to 3-fold increases in activity providing optimal protection. Protection from mitochondrial oxidation was confirmed by assessing aconitase activity, which was significantly improved in cells overexpressing MnSOD (P < 0.05). Data indicate that optimal protection from hyperoxic injury occurs in cells coexpressing MnSOD and glutathione peroxidase 1, with prevention of mitochondrial oxidation being a critical factor. This has important implications for clinical trials in preterm infants receiving SOD supplementation to prevent acute and chronic lung injury.


Subject(s)
Epithelial Cells/enzymology , Gene Expression Regulation, Enzymologic/physiology , Glutathione Peroxidase/genetics , Hyperoxia/physiopathology , Lung/cytology , Pulmonary Alveoli/enzymology , Superoxide Dismutase/genetics , Transgenes/physiology , Aconitate Hydratase/metabolism , Adenoviridae/genetics , Antioxidants/metabolism , Cell Proliferation , HeLa Cells , Humans , Hydrogen Peroxide , Lung/enzymology , Mitochondria/metabolism , Recombinant Proteins/metabolism
3.
Am J Respir Crit Care Med ; 169(6): 757-63, 2004 Mar 15.
Article in English | MEDLINE | ID: mdl-14701706

ABSTRACT

We have previously reported that dopamine increased active Na+ transport in rat lungs by upregulating the alveolar epithelial Na,K-ATPase. Here we tested whether alveolar epithelial cells produce dopamine and whether increasing endogenous dopamine production by feeding rats a 4% tyrosine diet (TSD) would increase lung liquid clearance. Alveolar Type II cells express the enzyme aromatic-L-amino acid decarboxylase (AADC) and, when incubated with the dopamine precursor, 3-hydroxy-L-tyrosine (L-dopa), produce dopamine. Rats fed TSD, a precursor of L-dopa and dopamine, had increased urinary dopamine levels, which were inhibited by benserazide, an inhibitor of AADC. Rats fed TSD for 15, 24, and 48 hours had a 26, 46, and 45% increase in lung liquid clearance, respectively, as compared with controls. Also, dopaminergic D1 receptor antagonist--but not dopaminergic D2 receptor antagonist--inhibited the TSD-mediated increase in lung liquid clearance. Alveolar Type II cells isolated from the lungs of rats after they had been fed TSD for 24 hours demonstrated increased protein abundance of Na,K-ATPase alpha1 and beta1 subunits. Basolateral membranes isolated from peripheral lung tissue of tyrosine-fed rats had increased Na,K-ATPase activity and Na,K-ATPase alpha1 subunit. These data provide the first evidence that alveolar epithelial cells produce dopamine and that increasing endogenous dopamine increases lung liquid clearance.


Subject(s)
Dopamine/biosynthesis , Epithelial Cells/enzymology , Pulmonary Alveoli/enzymology , Sodium-Potassium-Exchanging ATPase/metabolism , Tyrosine/physiology , Animals , Extravascular Lung Water/enzymology , Food, Fortified , Male , Rats , Rats, Sprague-Dawley , Up-Regulation/physiology
4.
Toxicol Pathol ; 31(2): 200-7, 2003.
Article in English | MEDLINE | ID: mdl-12696580

ABSTRACT

In tissue slice models, interactions between the heterogeneous cell types comprising the lung parenchyma are maintained thus providing a controlled system for the study of pulmonary toxicology in vitro. However, validation of the model in vitro system must be affirmed. Previous reports, in in vivo systems, have demonstrated that Clara cells and alveolar type II cells are the targets following inhalation of JP-8 jet fuel. We have utilized the lung slice model to determine if cellular targets are similar following in vitro exposure to JP-8. Agar-filled adult rat lung explants were cored and precision cut, using the Brende/Vitron tissue slicer. Slices were cultured on titanium screens located as half-cylinders in cylindrical Teflon cradles that were loaded into standard scintillation vials and incubated at 37 degrees C. Slices were exposed to JP-8 jet fuel (0.5 mg/ml, 1.0 mg/ml, and 1.5 mg/ml in medium) for up to 24 hours. We determined ATP content using a luciferin-luciferase bioluminescent assay. No significant difference was found between the JP-8 jet fuel doses or time points, when compared to controls. Results were correlated with structural alterations following aerosol inhalation of JP-8. As a general observation, ultrastructural evaluation of alveolar type cells revealed an apparent increase in the number and size of surfactant secreting lamellar bodies that was JP-8 jet fuel-dose dependent. These results are similar to those observed following aerosol inhalation exposure. Thus, the lung tissue slice model appears to mimic in vivo effects of JP-8 and therefore is a useful model system for studying the mechanisms of lunginjury following JP-8 exposure.


Subject(s)
Fossil Fuels/toxicity , Hydrocarbons/toxicity , Petroleum/toxicity , Pulmonary Alveoli/drug effects , Adenosine Triphosphate/metabolism , Administration, Inhalation , Aerosols , Animals , Dose-Response Relationship, Drug , Hydrocarbons/administration & dosage , Inclusion Bodies/drug effects , Inclusion Bodies/ultrastructure , Male , Microtomy/instrumentation , Organ Culture Techniques , Pulmonary Alveoli/enzymology , Pulmonary Alveoli/pathology , Rats , Rats, Sprague-Dawley
5.
Am J Respir Cell Mol Biol ; 22(1): 116-24, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10615073

ABSTRACT

Disaturated phosphatidylcholine (DSPC) is the predominate phospholipid component of lung surfactant. In the alveolar type II cell, the cytidine diphosphocholine (CDP-choline) pathway is the major biosynthetic pathway for DSPC. To investigate the hypothesis that phosphocholine cytidylyltransferase (CT) is the rate-limiting enzyme in the CDP-choline pathway, rat alveolar type II cells or lung tumor-derived cell lines (A549 or H441) with type II cell features were transfected with CT complementary DNA (cDNA). Cell fractions were subsequently assayed for CT protein and activity, and cell rates of DSPC synthesis were determined. In all cases, cell CT protein and activity were increased after transfection with CT cDNA but not after control transfection. Rat type II cells, but not A549 or H441 cells, increased the rate of DSPC synthesis after transfection with CT cDNA. Exposure of type II cells transfected with CT cDNA to palmitic acid resulted in a further increase in CT protein and activity. Exposure to dexamethasone resulted in increased CT protein and activity and increased synthesis of DSPC. The results confirm that CT has a rate-limiting and regulatory role in the synthesis of type II cell DSPC, and raise possibilities for novel therapeutic interventions.


Subject(s)
Choline-Phosphate Cytidylyltransferase/biosynthesis , Phosphatidylcholines/biosynthesis , Pulmonary Alveoli/enzymology , Pulmonary Alveoli/metabolism , Animals , Cell Fractionation , Cell Line , Choline-Phosphate Cytidylyltransferase/physiology , Cytosol/enzymology , Dexamethasone/pharmacology , Epithelium/drug effects , Epithelium/enzymology , Epithelium/metabolism , Immunoblotting , Plasmids/genetics , Pulmonary Alveoli/cytology , Pulmonary Alveoli/drug effects , Rats , Transfection
7.
Am J Respir Crit Care Med ; 152(2): 760-4, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7633739

ABSTRACT

Carboxypeptidase M (CPM) cleaves the C-terminal arginine and lysine of peptides; it is expressed in the lung, especially on the plasma membrane of alveolar type I cells. Here, we report on CPM in human bronchoalveolar lavage (BAL) collected from 69 patients and analyzed for activity, cell number and type, and protein level. Seventy-six percent of CPM activity, measured at pH 7.5 with 5-dimethylamino-naphthalene-1-sulfonyl-alanyl-arginine (Dansyl-Ala-Arg) substrate, was immunoprecipitated with polyclonal antibody to purified human enzyme. In patients without active lung disease, CPM activity in BAL was 7.69 (+/- 2.12) nmol/h/mg protein, but in patients with acute pneumonia, it was 29.25 (+/- 4.06) (p < 0.01). In patients with Pneumocystis carinii pneumonia, CPM activity was elevated to 26.00 (+/- 4.85) (p < 0.01) and in patients with lung cancer, to 30.95 (+/- 4.12) (p < 0.01). The activity was not associated with the cellular elements of BAL. The highest specific activity was in the large aggregate fraction of surfactant, which also contained the highest concentration of phosphorus. Transmission electron microscopy of this fraction revealed the presence of typical lamellar bodies and tubular myelin structures. The high CPM activity may stem from its induction and release in acute lung disease. In addition, CPM may be a marker of infection with certain pathogens and an indicator of type I cell injury in parenchymal lung diseases.


Subject(s)
Bronchoalveolar Lavage Fluid/chemistry , Lung Diseases/enzymology , Metalloendopeptidases/analysis , Alanine/metabolism , Arginine/metabolism , Bronchoalveolar Lavage Fluid/cytology , Cell Count , Cell Membrane/enzymology , Dansyl Compounds/metabolism , Female , GPI-Linked Proteins , Humans , Inclusion Bodies/ultrastructure , Lung Diseases/pathology , Lung Neoplasms/enzymology , Lung Neoplasms/pathology , Male , Microscopy, Electron , Middle Aged , Myelin Sheath/ultrastructure , Phosphorus/analysis , Pneumonia/enzymology , Pneumonia/pathology , Pneumonia, Pneumocystis/enzymology , Pneumonia, Pneumocystis/pathology , Precipitin Tests , Pulmonary Alveoli/enzymology , Pulmonary Alveoli/pathology , Pulmonary Surfactants/analysis
8.
Am J Respir Cell Mol Biol ; 4(4): 364-8, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1901719

ABSTRACT

This study tested whether adducts formed by covalent linkage of superoxide dismutase (SOD) or catalase to polyethylene glycol (PEG) could augment SOD and catalase activity in alveolar type II cells and document enhanced resistance to oxidant damage. Alveolar type II cells were isolated from adult, pathogen-free rats. Antioxidant enzymes were added to the medium of cell cultures in various concentrations for periods up to 48 h. Incubation with 500 to 3,000 U of PEG-SOD or 10,000 to 40,000 U of PEG-catalase/10(6) cells produced a dose-response-related increase in intracellular enzyme activity in comparison with controls (untreated or treated with SOD or catalase, inactivated PEG-SOD or PEG-catalase, or PEG alone). Uptake was maximal during the first 4 h. Using fluorescent label (fluorescein isothiocyanate) bound to PEG-catalase, we found intracellular localization of the labeled enzyme. Exposure to H2O2 led to reduced cytotoxicity in cells pretreated with PEG-catalase than in controls. We conclude that supplementation with PEG-SOD or PEG-catalase enhanced the activity of these enzymes in alveolar type II cells and increased their resistance to oxidant stress.


Subject(s)
Catalase/metabolism , Pulmonary Alveoli/enzymology , Superoxide Dismutase/metabolism , Animals , Catalase/pharmacology , Cells, Cultured , Fluorescein-5-isothiocyanate , Fluoresceins , Fluorescent Dyes , Germ-Free Life , Kinetics , L-Lactate Dehydrogenase/metabolism , Male , Polyethylene Glycols/pharmacology , Pulmonary Alveoli/cytology , Pulmonary Alveoli/drug effects , Rats , Superoxide Dismutase/pharmacology , Thiocyanates
9.
Agents Actions ; 28(3-4): 264-71, 1989 Nov.
Article in English | MEDLINE | ID: mdl-2596377

ABSTRACT

Cathepsin B and D activity was determined using specific synthetic substrates in alveolar macrophages (AMs) obtained from Sprague-Dawley rats with experimentally induced pulmonary granulomatous inflammation. Increased cathepsin B activity was found 4 days after intravenous injection of complete Freund's adjuvant (CFA), but not after injection of live bacillus Calmette-Guérin organisms (BCG), indicating that the enzyme response was unrelated to the subsequent development of granulomatous inflammation. Findings of comparable increases in enzyme activity following injection of mineral oil (MO) indicate that the response to CFA was due to the oil component. Significantly, oleic acid (OA), a natural fatty acid, did not stimulate enzyme activity although the agent, like MO, caused acute lung injury as assessed by 125I albumin uptake. At 7 and 28 days following injection of CFA, cathepsin B levels in AMs were the same as those in animals given normal saline (NS), although bronchoalveolar lavage (BAL) samples still contained increased numbers of AMs, and cells obtained at 28 days phagocytosed more polystyrene microspheres. Cathepsin D activity did not increase 4 days after injection of CFA or BCG + CFA; at 28 days following injection of BCG + CFA activity was significantly decreased as compared to animals given NS. The data reveal a differential response of two lysosomal enzymes during the early phases of granulomatous inflammation.


Subject(s)
Cathepsins/metabolism , Granuloma/enzymology , Lung Diseases/enzymology , Macrophages/enzymology , Albumins/pharmacokinetics , Animals , Cathepsin B/metabolism , Cathepsin D/metabolism , Granuloma/pathology , Inflammation/enzymology , Inflammation/pathology , Lung Diseases/chemically induced , Lung Diseases/pathology , Male , Phagocytosis , Pulmonary Alveoli/cytology , Pulmonary Alveoli/enzymology , Rats , Rats, Inbred Strains
10.
J Appl Toxicol ; 8(6): 393-8, 1988 Dec.
Article in English | MEDLINE | ID: mdl-2852684

ABSTRACT

The effects of inhalation of red phosphorus/butyl rubber (RP/BR) used as an obscurant smoke in tactical environments was examined. Sprague-Dawley male rats were exposed to 1000 mg/m3 of RP/BR for 3.5 h in single exposures, while in subsequent intermediate and subchronic studies the animals were exposed to concentrations ranging from 300 to 1200 mg/m3 for 2.25 h/day, 4 consecutive days/week for 4 and 13 weeks, respectively. Pulmonary bactericidal activity to inhaled [35S]-Klebsiella pneumoniae was depressed after the acute and the 13-week subchronic exposures but was unchanged after the 4-week exposures. The pulmonary free cells collected by lavage showed decreasing trends in total numbers, increased ATP levels and decreased ectoenzyme activity for 5'-nucleotidase after most of the exposures. Mild-to-moderate-to-severe terminal broncheolar fibrosis was observed in all rats after 4- and 13-week exposures to greater than or equal to 750 mg/m3 of RP/BR. The severity of the lesions increased with the severity of the exposure conditions. Except for the fibrosis, most changes were reversible.


Subject(s)
Macrophages/immunology , Phosphorus/toxicity , Pulmonary Alveoli/immunology , Rubber/toxicity , 5'-Nucleotidase , Adenosine Triphosphate/analysis , Administration, Inhalation , Animals , Bronchi/pathology , Cell Count/drug effects , Elastomers , Fibrosis , Klebsiella pneumoniae/immunology , Macrophages/drug effects , Male , Nucleotidases/analysis , Phagocytosis/drug effects , Pulmonary Alveoli/drug effects , Pulmonary Alveoli/enzymology , Rats , Rats, Inbred Strains
11.
Arch Toxicol ; 59(6): 402-7, 1987 Apr.
Article in English | MEDLINE | ID: mdl-3606384

ABSTRACT

The in vitro effects of straight chain alkanes (nC6-nC10), benzene and toluene on pulmonary alveolar macrophages (PAM) of rats and rabbits was studied. The concentrations used ranged from 0.02 to 1.0 mM. All hydrocarbons used in the study were cytotoxic to isolated cultured PAM cells in a dose-dependent manner. The LC50 for these hydrocarbons towards rat PAM cells was estimated to be 1.0 mM for nC8, 2 mM for nC7, 5 mM for nC9 and 10 mM for nC6, nC10, benzene and toluene. Rabbit PAM cells were more sensitive to the hydrocarbons, resulting in and LC50 half that for rat PAM cells. Hydrocarbons also caused extracellular release of the lysosomal enzymes cathepsin D (EC 3.4.23.5) and cathepsin B (EC 3.4.22.1) in a manner corresponding with cell damage. There was more cathepsin D activity released from cells than cathepsin B. In addition, hydrocarbons also caused the release of cathepsin B and D from isolated lysosomes, and there was 10-15% more enzyme activity released in the culture medium of lysosomes exposed to concentrations of 0.5 and 1.0 mM compared to PAM cell cultures of either rats or rabbits. Hydrocarbons also caused loss of cell respiration and stimulated a dose-dependent and a time-dependent increase in lipid peroxidation. The two alkanes nC7 and nC8 caused the greatest increase in lipid peroxidation and the greatest loss of cell respiration. The results indicate that there is a relationship between chain length of alkanes and their cytotoxicity to PAM cells.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Hydrocarbons/toxicity , Lysosomes/enzymology , Macrophages/drug effects , Petroleum/toxicity , Pulmonary Alveoli/enzymology , Toluene/toxicity , Alkanes/toxicity , Animals , Benzene/toxicity , Cell Survival/drug effects , Cells, Cultured , Lipid Peroxides/metabolism , Macrophages/metabolism , Male , Oxygen Consumption/drug effects , Pulmonary Alveoli/cytology , Rabbits , Rats , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL